A Methodology Study to Assess the Feasibility of Using Functional Magnetic Resonance Imaging to Quantify the Effects of Analgesic Drugs in Post-Traumatic Neuropathic Pain Subjects.
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2013
At a glance
- Drugs Pregabalin; Tramadol
- Indications Neuropathic pain
- Focus Pharmacodynamics
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 30 Nov 2012 Actual patient number changed from 20 to 18 as reported by ClinicalTrials.gov.
- 16 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.